K231688 is an FDA 510(k) clearance for the ImPACT Version 4. This device is classified as a Computerized Cognitive Assessment Aid For Concussion (Class II - Special Controls, product code POM).
Submitted by Impact Applications, Inc. (Coralville, US). The FDA issued a Cleared decision on September 16, 2023, 99 days after receiving the submission on June 9, 2023.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1471. For Use As An Assessment Aid In The Management Of Concussion..